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Editorial: COVID-19 Pandemic, the Second Wave, and Provision of Cancer 
Services
Severe acute respiratory syndrome coronavirus 
2 (SARS-CoV-2) (COVID-19) pandemic continues 
to have a massive effect on health worldwide, 
with 80.6 million cases and 1.76 million deaths 
reported so far. It has crippled the world 
economy, and major multinational companies 
have declared bankruptcies. In Pakistan, it has 
affected 471,000 people, with 9874 deaths 
reported. The second wave has not had an effect 
similar to what was seen during June 2020. On 
average, approximately 2700 cases are being 
reported daily, with roughly 60 people falling 
victim to this deadly virus every day. Testing 
capacity in the country has been increased, and 
almost 40,000 people are being tested every day 
for SARS-CoV-2 polymerase chain reaction (PCR). 
The numbers seem to have plateaued during the 
past 1 week. The overall positivity rate for Shaukat 
Khanum Memorial Cancer Hospital and Research 
Centre (SKMCH and RC) in Lahore and Peshawar 
has been around 15%. So far, we have had 124 
and 24 employees testing positive at Lahore and 
Peshawar, respectively.
Cancer services at both the hospitals of SKMCH and 
RC have continued in full swing during the current 
period. Screening counters have been established 
at various entry points to the hospital, and 
outpatient services continue to follow a stringent 
attendant policy. Besides, almost all the follow-up 
appointments have been converted to telemedicine 
clinics. Chemotherapy and radiotherapy sessions 
are back to where they were during pre-COVID 
times. We have increased the day case surgeries, 
which now represent approximately 45% of the 
total surgical oncology numbers, which are also at 
the routine which was being followed in January 
2020. It is ensured that all the patients except for 
those requiring emergent surgical procedures 
undergo pre-surgery PCR for SARS-CoV-2. A similar 
rule is followed for those undergoing endoscopies. 
Personal protective equipment (PPE) guidelines, 
especially those applicable to various hospital 
procedures, are published and revised regularly 
by the infection control. This is in addition to the 
creation of a Stockpile for PPEs and essentials such 
as availability of oxygen and diagnostic reagents. 
Infection control does a daily hospital round, which 
has been divided into three zones (green, yellow 
and red) based on the risk of infection, to ensure 
PPE and compliance with other hospital rules 
related to COVID-19.
Diagnostic and imaging services continue to 
provide ever-expanding services at the main 
hospital and the offshoot diagnostic centres in 
Lahore. We have been conducting SARS-CoV-2 
testing for all major airlines while at the same time 
continuing to provide home and drive through 
sampling in major cities of the country. The 
laboratory is performing approximately 800 PCRs 
daily on a completely automated Cobas 6800 
analyser.
As part of the national effort to counter this deadly 
disease, SKMCH and RC has been involved in 
the national SARS-CoV-2 vaccine trial being 
conducted by the National Institute of Health. 
With the availability of COVID-19 vaccine in the 
first world, the effort of the Pakistan government 
to secure it and to ensure that those at the 
highest risk of contracting the virus is offered 
this first, SKMCH and RC has created a list of 
front line health care workers (HCW) involved in 
the COVID-19 effort and those cancer patients 
on active treatment so that these HCW and 
cancer patients (being most at risk) could be the 
first ones to be offered the vaccine. The list of 
front line HCW has also been uploaded on the 
government’s national database created by the 
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National Command and Operation Centre. The 
government has indicated that the vaccine is 
likely to be available at the end of the first quarter 
of 2021.
All of the above and its compliance are monitored 
twice weekly by relevant stakeholders from 
both hospitals in a meeting headed by the chief 
executive officer of SKMCH and RC.
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